eHealth (EHTH)

• eHealth reported strong financial results for fiscal year 2025, with annual revenue growing 4%, GAAP net income increasing by almost 300% to $40 million, and Adjusted EBITDA rising 40% to $97.3 million.
• For fiscal year 2026, the company provided guidance projecting a significant decline in financial performance, with total revenue expected between $405 million and $445 million, GAAP net income between $8 million and $25 million, and Adjusted EBITDA between $55 million and $75 million.
• This outlook reflects a strategic shift in 2026 to prioritize operating cash flow and quality over enrollment volume, including planned cost reductions of over $90 million compared to 2025 and a focus on higher-margin marketing channels.
• The company aims to achieve break-even operating cash flow in 2026, representing a $25 million year-over-year improvement at the midpoint, with positive operating cash flow targeted for 2027.

• eHealth reported total revenue of $326.2 million for Q4 2025, a 4% year-over-year increase, and $554.0 million for FY 2025, also up 4% year-over-year.
• FY 2025 GAAP net income significantly increased to $40.0 million from $10.1 million in FY 2024, despite Q4 2025 GAAP net income declining 11% to $87.2 million compared to Q4 2024.
• Adjusted EBITDA for Q4 2025 grew 10% year-over-year to $132.9 million, and FY 2025 Adjusted EBITDA increased 40% year-over-year to $97.3 million.
• The commissions receivable balance grew 12% to $1.1 billion as of December 31, 2025, while total Medicare Advantage submissions declined 3% for FY 2025 and 4% for Q4 2025, reflecting a strategic focus on unit economics and profitability.
• For FY 2026, the company provided guidance projecting total revenue between $405 million and $445 million, GAAP net income between $8 million and $25 million, and Adjusted EBITDA between $55 million and $75 million.

• eHealth reported strong fiscal year 2025 financial results, with annual revenue growing 4% to $554 million, GAAP net income increasing almost 300% to $40 million, and Adjusted EBITDA rising 40% to $97.3 million.
• For Q4 2025, revenue reached a company record of $326.2 million, up 4%, and Adjusted EBITDA increased 10% to $132.9 million. The company also reported $1.1 billion in total commissions receivable as of December 31, 2025, up 12% year-over-year.
• The company issued 2026 guidance, projecting total revenue between $405 million and $445 million, GAAP net income between $8 million and $25 million, and Adjusted EBITDA between $55 million and $75 million. This outlook reflects a strategic prioritization of operating cash flow and quality over enrollment volume.
• eHealth plans significant cost reductions in 2026, including approximately $30 million in fixed operating costs and over $60 million in variable spend, for an overall year-over-year spend reduction greater than $90 million, aiming for break-even operating cash flow for the year.

• eHealth reported fiscal year 2025 total revenue of $554 million, a 4% increase year-over-year, with GAAP net income of $40 million (up almost 300%) and Adjusted EBITDA of $97.3 million (up 40%). For Q4 2025, the company achieved a record revenue of $326.2 million, up 4%, and Adjusted EBITDA of $132.9 million, an increase of 10%.
• For 2026, eHealth expects total revenue to be in the range of $405 million to $445 million, GAAP net income between $8 million and $25 million, and Adjusted EBITDA between $55 million and $75 million.
• The company is prioritizing operating cash flow and quality in 2026, aiming for break-even operating cash flow (range of -$10 million to +$12 million) this year, representing a $25 million year-over-year improvement. This will be achieved through cost reductions of over $90 million (including $30 million in fixed costs and over $60 million in variable spend) and focusing on highest margin marketing channels.
• Strategic initiatives for 2026 include developing a lifetime advisory engagement model, broadening its non-Medicare Advantage portfolio (such as ICHRA and ancillary products), and continued cost discipline. The company views 2026 as a "bridge year" to position for growth in 2027.

• eHealth, Inc. reported total revenue of $326.2 million for Q4 2025, a 4% increase compared to Q4 2024, and $554.0 million for FY 2025, also a 4% increase over FY 2024.
• For Q4 2025, GAAP net income was $87.2 million (down 11% year-over-year) and adjusted EBITDA was $132.9 million (up 10% year-over-year). For FY 2025, GAAP net income was $40.0 million (a significant increase from $10.1 million in FY 2024) and adjusted EBITDA was $97.3 million (up 40% year-over-year).
• The company ended FY 2025 with a commissions receivable balance of $1.1 billion, marking a 12% increase compared to December 31, 2024.
• eHealth enhanced its financial flexibility by replacing a $70.0 million term loan with a $125.0 million asset-based revolving credit facility that matures in December 2028.
• For the full year ending December 31, 2026, eHealth provided guidance expecting total revenue between $405.0 million and $445.0 million, GAAP net income between $8.0 million and $25.0 million, and adjusted EBITDA between $55.0 million and $75.0 million. Operating cash flow is projected to be between $(10.0) million and $12.0 million.

• eHealth announced a new company vision and growth strategy focused on providing trusted, lifelong guidance on health coverage, shifting from a transaction-driven enrollment model to an ongoing relationship model.
• This strategy is expected to drive increased member lifetime value, improve member retention, and build on brand recognition, with plans to expand ancillary products and adjacent services that are anticipated to have favorable cash flow dynamics.
• The company will invest in enhanced technology, integrated data, advisor enablement tools, and a comprehensive service ecosystem, leveraging AI and advanced analytics to support this vision.
• An eHealth survey validates the strategy, revealing that 90% of Americans believe health insurance selection is broken and 87% desire year-round advisor support.

• eHealth, Inc. announced a new $125 million asset-based revolving credit facility with Manulife | Comvest Credit Partners, entered into on December 31, 2025.
• The proceeds were primarily used to repay approximately $70 million outstanding under the previous Blue Torch Loan.
• The remaining funds will support strategic growth initiatives, including investments in AI-driven capabilities and omni-channel technology, and for general corporate purposes.
• This new facility offers favorable pricing (SOFR + 6.50%) and a three-year maturity until December 2028, providing greater financial flexibility.
• In connection with the credit facility, eHealth amended its investment agreement with H.I.G., introducing a liquidity covenant that, if breached, could lead to a 2.00% increase in the paid-in-kind dividend rate for the Series A Preferred Stock.

• eHealth, Inc. has entered into a new $125 million asset-based revolving credit facility with Manulife | Comvest Credit Partners.
• The Credit Facility offers favorable pricing (SOFR + 6.50%) and a three-year maturity, providing greater financial flexibility and stability.
• A portion of the proceeds, approximately $70 million, was used to repay the outstanding Blue Torch Loan.
• The remaining proceeds will support strategic growth initiatives, including investments in AI-driven capabilities and omni-channel technology, and for general corporate purposes.
• The Company also intends to further improve its capital structure by addressing its convertible Series A preferred stock.

• eHealth, Inc. has updated its guidance ranges for the fiscal year ending December 31, 2025, following strong Annual Enrollment Period (AEP) performance.
• The company now expects total revenue to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million.
• GAAP net income (loss) guidance has been revised upwards to a range of $30 million to $45 million, from the previous range of $9.0 million to $30.0 million.
• Adjusted EBITDA is also expected to be higher, ranging from $80 million to $95 million, compared to the prior range of $60 million to $80 million.
• Operating cash flow is anticipated to be in the range of $(25.0) million to $0 million, compared to the prior range of $(25.0) million to $10.0 million, and includes positive net adjustment revenue expected between $40 million and $45 million.

• eHealth, Inc. (EHTH) has updated its fiscal year 2025 guidance following its Annual Enrollment Period (AEP) performance, as of December 18, 2025.
• The company reported that AEP enrollment volume and revenue were within expectations, while outperforming on profitability.
• eHealth anticipates a meaningful year-over-year increase in fourth quarter MA constrained lifetime value (LTV) of commissions, driven by higher MA commission rates for plan year '26 and favorable persistency trends.

Below is the updated guidance for the fiscal year ending December 31, 2025, compared to prior ranges: